MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$83,340K
Net loss
-$83,233K
(-420.69%↓ Y/Y)
Unrealized loss on
available-for-sale investments
-$107K
Interest income, net
$5,395K
(190.21%↑ Y/Y)
Net loss from
continuing operations
-$83,233K
(-435.78%↓ Y/Y)
Total other income,
net
$5,395K
(190.21%↑ Y/Y)
Loss from operations
-$88,628K
(-409.53%↓ Y/Y)
Total operating
expenses
$88,628K
(409.53%↑ Y/Y)
Acquired in-process
research and development
$45,000K
Research and development
$35,529K
(185.86%↑ Y/Y)
General and
administrative
$8,099K
(63.12%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cidara Therapeutics, Inc. (CDTX)
Cidara Therapeutics, Inc. (CDTX)